查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786884

臨床腫瘤學次世代定序市場，規模，佔有率，趨勢，產業分析報告:各技術，工作流程，各用途，各最終用途，各地區，2025年～2034年的市場預測

Clinical Oncology Next Generation Sequencing Market Size, Share, Trends, Industry Analysis Report By Technology (Whole Genome Sequencing, Whole Exome Sequencing), By Workflow, By Application, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，臨床腫瘤學新一代定序 (NGS) 市場規模預計到2034年將達到22.0879億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

臨床腫瘤學新一代定序 (NGS) 是一種高通量基因組技術，能夠全面分析腫瘤DNA和RNA，從而識別致癌突變、拷貝數變異、基因融合和其他分子變異。這項技術正在徹底改變精準腫瘤學，使臨床醫生能夠以前所未有的精確度識別可操作的分子標靶、預測治療反應並監測病情進展。

新一代定序透過識別新型生物標記物並招募患者參與基因型匹配的臨床試驗，推動了癌症研究的發展。儘管該技術具有變革性的潛力，但也面臨著腫瘤異質性、複雜的數據解讀和成本障礙等課題。然而，單細胞定序、長讀長技術和人工智慧的進步正在提高新一代定序的準確性和可及性，從而推動市場成長。

臨床腫瘤學新一代定序市場報告重點

就技術而言，標靶定序和重定序領域預計將在2024年佔據64.93%的市場收入佔有率，這得益於成本效益、深度覆蓋以及能夠聚焦特定基因或基因組區域的優勢。

按工作流程劃分，預計定序領域在2024年將佔據57.03%的市場收入佔有率，這得益於對能夠準確分析癌症基因組的高通量、高精度和高性價比平台的需求激增。

依應用劃分，伴隨診斷領域在2024年以71.83%的營收佔有率領先市場。這種主導地位歸因於FDA批准的相關基因生物標記的抗癌藥物數量的增加。

依最終用途劃分，由於向分散檢測和即時診斷的轉變，臨床領域預計在未來幾年的複合年增長率將達到19.21%。

在2024年全球臨床腫瘤學次世代定序 (NGS) 市場中，北美佔44.16%的市佔率。這種主導地位歸因於癌症的高發生率、先進的醫療基礎設施以及精準醫療的廣泛應用。

由於癌症患者數量的增加、政府的支持性政策以及對基因組醫學的投資不斷增加，預計到 2034 年，歐洲市場將佔據相當大的市場佔有率。

預計亞太地區市場在預測期內將達到最高的複合年增長率。這是由於癌症負擔的增加、醫療保健可近性的改善以及對基因組醫學的投資增加。

全球主要市場參與者包括安捷倫科技、Eurofins Scientific S.E.、F. Hoffmann-La Roche Ltd.、Illumina, Inc.、Myriad Genetics、Oxford Nanopore Technologies Ltd.、Pacific Bioscience、Perkin Elmer、Qiagen N.V. 和賽默飛世爾科技。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球臨床腫瘤學次世代定序市場洞察

  • 市場概述
  • 臨床腫瘤學次世代定序市場動態
    • 促進因素和機會
      • 科技進步加速，
      • 醫療成本不斷上漲
    • 限制與課題
      • 成本高昂
  • PESTEL分析
  • 臨床腫瘤學次世代定序市場趨勢
  • 價值鏈分析

第5章 全球臨床腫瘤學次世代定序市場:各技術

  • 主要調查結果
  • 簡介
  • 全基因排列分析
  • 全外顯子定序
  • 標靶定序與重定序

第6章 全球臨床腫瘤學次世代定序市場:各用途

  • 主要調查結果
  • 簡介
  • 篩檢
  • 伴隨式診斷
  • 其他

第7章 全球臨床腫瘤學次世代定序市場:工作流程

  • 主要調查結果
  • 簡介
  • 前序列
  • 定序
  • 資料分析

第8章 全球臨床腫瘤學次世代定序市場:各最終用途

  • 主要調查結果
  • 簡介
  • 醫院
  • 診所
  • 其他

第9章 全球臨床腫瘤學次世代定序市場:各地區

  • 主要調查結果
  • 簡介
    • 臨床腫瘤學次世代定序市場評估:各地區，2020～2034年
  • 北美
    • 北美:各技術，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各工作流程，2020～2034年
    • 北美:各最終用途，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各技術，2020～2034年
    • 歐洲:各用途，2020～2034年
    • 歐洲:各工作流程，2020～2034年
    • 歐洲:各最終用途，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各技術，2020～2034年
    • 亞太地區:各用途，2020～2034年
    • 亞太地區:各工作流程，2020～2034年
    • 亞太地區:各最終用途，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各技術，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 中東·非洲:各工作流程，2020～2034年
    • 中東·非洲:各最終用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各技術，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各工作流程，2020～2034年
    • 南美:各最終用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Agilent Technologies
  • Eurofins Scientific S.E.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Myriad Genetics
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience
  • Perkin Elmer
  • Qiagen N.V.
  • Thermo Fisher Scientific
Product Code: PM5960

The Clinical oncology next generation sequencing (NGS) market size is expected to reach USD 2,208.79 million by 2034, according to a new study by Polaris Market Research. The report "Clinical Oncology Next Generation Sequencing Market Share, Size, Trends, Industry Analysis Report By Technology (Whole Genome Sequencing, Whole Exome Sequencing), By Workflow, By Application, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Clinical oncology next generation sequencing (NGS) is a high-throughput genomic technology that enables comprehensive analysis of tumor DNA and RNA to identify cancer-driving mutations, copy number variations, gene fusions, and other molecular alterations. This technology is revolutionizing precision oncology by allowing clinicians to identify actionable molecular targets, predict treatment responses, and monitor disease progression with unprecedented accuracy.

Next generation sequencing fuels cancer research by identifying novel biomarkers and enrolling patients in genotype-matched clinical trials. Despite its transformative potential, the technology faces challenges such as tumor heterogeneity, data interpretation complexity, and cost barriers. However, advancements in single-cell sequencing, long-read technologies, and artificial intelligence are enhancing NGS accuracy and accessibility, driving market growth.

Clinical Oncology Next Generation Sequencing Market Report Highlights

In terms of technology, the targeted sequencing & resequencing segment accounted for 64.93% of market revenue share in 2024 due to its cost-effectiveness, high depth of coverage, and ability to focus on specific genes or genomic regions.

Based on workflow, the sequencing segment held 57.03% of market revenue share in 2024 due to a surge in demand for high-throughput, accurate, and cost-efficient platforms capable of analyzing cancer genomes with increased precision.

In terms of application, the companion diagnostics segment led the market in 2024 by capturing 71.83% revenue share. This dominance is attributed to the rising number of FDA-approved cancer drugs with associated genetic biomarkers.

Based on end use, the clinics segment is projected to register a CAGR of 19.21% in the coming years, owing to the shift toward decentralized testing and point-of-care diagnostics.

North America accounted for a 44.16% share of the global clinical oncology next generation sequencing (NGS) market in 2024. This dominance is attributed to the high prevalence of cancer, advanced healthcare infrastructure, and strong adoption of precision medicine.

The market in Europe is projected to hold a substantial market share in 2034, owing to increasing cancer cases, supportive government policies, and rising investments in genomic medicine.

The market in Asia Pacific is expected to register the highest CAGR during the forecast period, owing to the rising cancer burden, improving healthcare access, and increasing investments in genomics.

A few global key market players include Agilent Technologies; Eurofins Scientific S.E.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Myriad Genetics; Oxford Nanopore Technologies Ltd.; Pacific Bioscience; Perkin Elmer; Qiagen N.V.; and Thermo Fisher Scientific.

Polaris Market Research has segmented the clinical oncology next generation sequencing market report on the basis of technology, workflow, application, end use, and region:

By Technology Outlook (Revenue, USD Million, 2020-2034)

Whole Genome Sequencing

Whole Exome Sequencing

Targeted Sequencing & Resequencing

By Workflow Outlook (Revenue, USD Million, 2020-2034)

Pre-Sequencing

Sequencing

Data Analysis

By Application Outlook (Revenue, USD Million, 2020-2034)

Screening

Sporadic Cancer

Inherited Cancer

Companion Diagnostics

Other

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Clinics

Laboratories

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Clinical Oncology Next Generation Sequencing Market Insights

  • 4.1. Clinical Oncology Next Generation Sequencing Market - Market Snapshot
  • 4.2. Clinical Oncology Next Generation Sequencing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Technological Advancements,
      • 4.2.1.2. Rising Healthcare Spending
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Clinical Oncology Next Generation Sequencing Market Trends
  • 4.6. Value Chain Analysis

5. Global Clinical Oncology Next Generation Sequencing Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • 5.3. Whole Genome Sequencing
    • 5.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Whole Genome Sequencing, by Region, 2020-2034 (USD Million)
  • 5.4. Whole Exome Sequencing
    • 5.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Whole Exome Sequencing, by Region, 2020-2034 (USD Million)
  • 5.5. Targeted Sequencing & Resequencing
    • 5.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Targeted Sequencing & Resequencing, by Region, 2020-2034 (USD Million)

6. Global Clinical Oncology Next Generation Sequencing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • 6.3. Screening
    • 6.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Screening, by Region, 2020-2034 (USD Million)
    • 6.3.2. Sporadic Cancer
      • 6.3.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Sporadic Cancer, by Region, 2020-2034 (USD Million)
    • 6.3.3. Inherited Cancer
      • 6.3.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Inherited Cancer, by Region, 2020-2034 (USD Million)
  • 6.4. Companion Diagnostics
    • 6.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Companion Diagnostics, by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Clinical Oncology Next Generation Sequencing Market, by Workflow

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • 7.3. Pre-Sequencing
    • 7.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Pre-Sequencing, by Region, 2020-2034 (USD Million)
  • 7.4. Sequencing
    • 7.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Sequencing, by Region, 2020-2034 (USD Million)
  • 7.5. Data Analysis
    • 7.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Data Analysis, by Region, 2020-2034 (USD Million)

8. Global Clinical Oncology Next Generation Sequencing Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 8.3. Hospitals
    • 8.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Hospitals, by Region, 2020-2034 (USD Million)
  • 8.4. Clinics
    • 8.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Clinics, by Region, 2020-2034 (USD Million)
  • 8.5. Others
    • 8.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Clinical Oncology Next Generation Sequencing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Clinical Oncology Next Generation Sequencing Market Assessment, By Geography, 2020-2034 (USD Million)
  • 9.3. Clinical Oncology Next Generation Sequencing Market - North America
    • 9.3.1. North America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.2. North America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.3.3. North America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.3.4. North America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.3.5. Clinical Oncology Next Generation Sequencing Market - US
      • 9.3.5.1. US: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.3.5.2. US: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.3.5.3. US: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.3.5.4. US: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.3.6. Clinical Oncology Next Generation Sequencing Market - Canada
      • 9.3.6.1. Canada: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.3.6.2. Canada: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.3.6.3. Canada: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.3.6.4. Canada: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4. Clinical Oncology Next Generation Sequencing Market - Europe
    • 9.4.1. Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.2. Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.3. Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.4. Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.5. Clinical Oncology Next Generation Sequencing Market - UK
      • 9.4.5.1. UK: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.5.2. UK: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.5.3. UK: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.5.4. UK: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.6. Clinical Oncology Next Generation Sequencing Market - France
      • 9.4.6.1. France: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.6.2. France: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.6.3. France: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.6.4. France: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.7. Clinical Oncology Next Generation Sequencing Market - Germany
      • 9.4.7.1. Germany: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.7.2. Germany: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.7.3. Germany: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.7.4. Germany: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.8. Clinical Oncology Next Generation Sequencing Market - Italy
      • 9.4.8.1. Italy: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.8.2. Italy: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.8.3. Italy: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.8.4. Italy: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.9. Clinical Oncology Next Generation Sequencing Market - Spain
      • 9.4.9.1. Spain: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.9.2. Spain: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.9.3. Spain: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.9.4. Spain: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.10. Clinical Oncology Next Generation Sequencing Market - Netherlands
      • 9.4.10.1. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.10.2. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.10.3. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.10.4. Netherlands: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.11. Clinical Oncology Next Generation Sequencing Market - Russia
      • 9.4.11.1. Russia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.11.2. Russia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.11.3. Russia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.11.4. Russia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.12. Clinical Oncology Next Generation Sequencing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.12.2. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.12.3. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.12.4. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5. Clinical Oncology Next Generation Sequencing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.2. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.3. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.4. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.5. Clinical Oncology Next Generation Sequencing Market - China
      • 9.5.5.1. China: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.5.2. China: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.5.3. China: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.5.4. China: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.6. Clinical Oncology Next Generation Sequencing Market - India
      • 9.5.6.1. India: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.6.2. India: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.6.3. India: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.6.4. India: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.7. Clinical Oncology Next Generation Sequencing Market - Malaysia
      • 9.5.7.1. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.7.2. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.7.3. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.7.4. Malaysia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.8. Clinical Oncology Next Generation Sequencing Market - Japan
      • 9.5.8.1. Japan: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.8.2. Japan: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.8.3. Japan: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.8.4. Japan: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.9. Clinical Oncology Next Generation Sequencing Market - Indonesia
      • 9.5.9.1. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.9.2. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.9.3. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.9.4. Indonesia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.10. Clinical Oncology Next Generation Sequencing Market - South Korea
      • 9.5.10.1. South Korea: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.10.2. South Korea: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.10.3. South Korea: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.10.4. South Korea: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.11. Clinical Oncology Next Generation Sequencing Market - Australia
      • 9.5.11.1. Australia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.11.2. Australia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.11.3. Australia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.11.4. Australia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.12. Clinical Oncology Next Generation Sequencing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.6. Clinical Oncology Next Generation Sequencing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.2. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.6.3. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.6.4. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.5. Clinical Oncology Next Generation Sequencing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.5.2. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.5.3. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.5.4. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.6. Clinical Oncology Next Generation Sequencing Market - UAE
      • 9.6.6.1. UAE: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.6.2. UAE: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.6.3. UAE: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.6.4. UAE: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.7. Clinical Oncology Next Generation Sequencing Market - Israel
      • 9.6.7.1. Israel: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.7.2. Israel: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.7.3. Israel: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.7.4. Israel: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.8. Clinical Oncology Next Generation Sequencing Market - South Africa
      • 9.6.8.1. South Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.8.2. South Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.8.3. South Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.8.4. South Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.9. Clinical Oncology Next Generation Sequencing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.7. Clinical Oncology Next Generation Sequencing Market - Latin America
    • 9.7.1. Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.2. Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.7.3. Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.7.4. Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.7.5. Clinical Oncology Next Generation Sequencing Market - Mexico
      • 9.7.5.1. Mexico: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.7.5.2. Mexico: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.7.5.3. Mexico: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.7.5.4. Mexico: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.7.6. Clinical Oncology Next Generation Sequencing Market - Brazil
      • 9.7.6.1. Brazil: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.7.6.2. Brazil: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.7.6.3. Brazil: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.7.6.4. Brazil: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.7.7. Clinical Oncology Next Generation Sequencing Market - Argentina
      • 9.7.7.1. Argentina: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.7.7.2. Argentina: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.7.7.3. Argentina: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.7.7.4. Argentina: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.7.8. Clinical Oncology Next Generation Sequencing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.7.8.2. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.7.8.3. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.7.8.4. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Agilent Technologies
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Eurofins Scientific S.E.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. F. Hoffmann-La Roche Ltd.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Illumina, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Myriad Genetics
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Oxford Nanopore Technologies Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Pacific Bioscience
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Perkin Elmer
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Qiagen N.V.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Thermo Fisher Scientific
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables:

  • Table 1 Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 2 Global Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 4 Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 5 North America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 6 North America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 7 North America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 8 North America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 9 U.S.: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 10 U.S.: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 11 U.S.: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 12 U.S.: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 13 Canada: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 14 Canada: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 15 Canada: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 16 Canada: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 17 Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 18 Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 19 Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 20 Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 21 UK: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 22 UK: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 23 UK: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 24 UK: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 25 France: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 26 France: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 27 France: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 28 France: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 29 Germany: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 30 Germany: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 31 Germany: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 32 Germany: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 33 Italy: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 34 Italy: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 35 Italy: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 36 Italy: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Spain: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 38 Spain: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 39 Spain: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 40 Spain: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 42 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 43 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 44 Netherlands: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 45 Russia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 46 Russia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 47 Russia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 48 Russia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 49 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 50 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 51 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 52 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 53 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 54 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 55 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 56 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 57 China: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 58 China: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 59 China: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 60 China: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 61 India: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 62 India: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 63 India: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 64 India: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 65 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 66 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 67 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 68 Malaysia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 69 Japan: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 70 Japan: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 71 Japan: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 72 Japan: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 73 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 74 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 75 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 76 Indonesia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 77 South Korea: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 78 South Korea: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 79 South Korea: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 80 South Korea: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 81 Australia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 82 Australia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 83 Australia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 84 Australia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 85 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 86 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 87 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 88 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 89 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 90 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 91 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 92 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 93 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 94 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 95 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 96 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 97 UAE: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 98 UAE: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 99 UAE: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 100 UAE: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 101 Israel: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 102 Israel: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 103 Israel: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 104 Israel: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 105 South Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 106 South Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 107 South Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 108 South Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 109 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 110 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 111 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 112 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 113 Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 114 Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 115 Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 116 Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 117 Mexico: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 118 Mexico: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 119 Mexico: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 120 Mexico: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 121 Brazil: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 122 Brazil: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 123 Brazil: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 124 Brazil: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 125 Argentina: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 126 Argentina: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 127 Argentina: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 128 Argentina: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 129 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 130 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 131 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 132 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Clinical Oncology Next Generation Sequencing Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Technology
  • Figure 7. Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Clinical Oncology Next Generation Sequencing Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by Workflow
  • Figure 11. Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2024 & 2034 (USD Million)
  • Figure 12. Market by End Use
  • Figure 13. Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2024 & 2034 (USD Million)